IPSC · Century Therapeutics, Inc. · Executive Compensation
$1.53
-0.08 (-4.97%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$302.40M
Shares
181.08M
Volume · Oct 2
802.96K
Avg daily vol (3M)
643.93K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Joseph Truitt | member of the Board | Appointed | 2026-09-09 |
| Carlo Rizzuto, Ph.D. | board of directors | Resigned | 2025-12-29 |
| Dr. Han Lee | director | Appointed | 2025-12-09 |
| Dr. Martin Murphy | director | Appointed | 2025-12-09 |
| Brent Pfeiffenberger, Pharm.D. | Chairman of the Board | Appointed | 2025-08-14 |
| Douglas Carr | interim Principal Financial Officer | Appointed | 2025-07-07 |
| Adrienne Farid, Ph.D. | Chief Development Officer | Terminated | 2025-07-07 |
| Morgan Conn, Ph.D. | Chief Financial Officer | Terminated | 2025-07-07 |
| Morgan Conn, Ph.D. | Chief Financial Officer | Appointed | 2024-09-26 |
| Michael C. Diem, M.D. | Chief Financial Officer | Resigned | 2024-01-19 |
| Gregory Russotti | Chief Technology and Manufacturing Officer | Appointed | 2023-11-14 |
| Brent Pfeiffenberger | member of the Board | Appointed | 2023-11-14 |
| Brent Pfeiffenberger | President and Chief Executive Officer | Appointed | 2023-11-14 |
| Michael Diem | Chief Financial Officer | Appointed | 2023-04-17 |
| Gregory Russotti | Interim President and Chief Executive Officer | Appointed | 2023-04-17 |
| Osvaldo Flores, Ph.D. | member of the Board of Directors | Resigned | 2023-04-17 |
| Osvaldo Flores, Ph.D. | President and Chief Executive Officer | Resigned | 2023-04-17 |
| Timothy P. Walbert | Class II Director | Appointed | 2022-10-03 |
| Daphne Quimi | Class I Director | Appointed | 2022-10-03 |
| Eli Casdin | Class I Director | Resigned | 2022-10-03 |